Androgen receptor overexpression in prostate cancer in type 2 diabetes

OBJECTIVE: While prostate cancer does not occur more often in men with diabetes, survival is markedly reduced in this patient group. Androgen signaling is a known and major driver for prostate cancer progression. Therefore, we analyzed major components of the androgen signaling chain and cell prolif...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Stefan Zoltán, Hennenlotter, Jörg, Scharpf, Marcus Oliver, Sailer, Corinna, Fritsche, Louise, Schmid, Vera, Kantartzis, Konstantinos, Wagner, Robert, Lehmann, Rainer, Berti, Lucia, Peter, Andreas, Staiger, Harald, Fritsche, Andreas, Fend, Falko, Todenhöfer, Tilman, Stenzl, Arnulf, Häring, Hans-Ulrich, Heni, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985051/
https://www.ncbi.nlm.nih.gov/pubmed/29249638
http://dx.doi.org/10.1016/j.molmet.2017.11.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985051/
https://www.ncbi.nlm.nih.gov/pubmed/29249638
http://dx.doi.org/10.1016/j.molmet.2017.11.013

Ejemplares similares